457
Views
5
CrossRef citations to date
0
Altmetric
Drug Profiles

Canakinumab for the treatment of systemic juvenile idiopathic arthritis

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

F La Torre, MC Caparello & R Cimaz. (2017) Canakinumab for the treatment of TNF-receptor associated periodic syndrome. Expert Review of Clinical Immunology 13:6, pages 513-523.
Read now
Nico M Wulffraat. (2015) A safety evaluation of canakinumab for the treatment of systemic onset juvenile idiopathic arthritis. Expert Opinion on Drug Safety 14:12, pages 1961-1967.
Read now

Articles from other publishers (3)

Wen-Jia Zhao, Jiang-Hong Deng & Cai-Feng Li. (2022) Research progress in drug therapy of juvenile idiopathic arthritis. World Journal of Pediatrics 18:6, pages 383-397.
Crossref
A. Santimov & A.A. Grom. 2016. Pediatrics in Systemic Autoimmune Diseases. Pediatrics in Systemic Autoimmune Diseases 503 525 .
Fiona Moghaddas & Seth L. Masters. (2015) Monogenic autoinflammatory diseases: Cytokinopathies. Cytokine 74:2, pages 237-246.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.